Michael A. Sherman - Jan 17, 2023 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role: Chief Executive Officer, Director
Signature: /s/ Michael Alrutz, Attorney-in-Fact
Stock symbol: CMRX
Transactions as of: Jan 17, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/19/2023, 08:46 PM
Previous filing: Jul 27, 2022
Next filing: May 16, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMRX	Common Stock	Award	$0	+93K	+71.48%	$0.00	223K	Jan 17, 2023	Direct	F1, F2
holding	CMRX	Common Stock						103K	Jan 17, 2023	By Sherman Investors LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRX	Stock Option (Right to Buy)	Award	$0	+557K		$0.00	557K	Jan 17, 2023	Common Stock	557K	$1.97	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 23,237 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 23,237 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 23,237 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 23,239 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
F2	Includes 4,681 shares acquired under the Issuer's Employee Stock Purchase Plan on September 9, 2022.
F3	1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.